P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2006 to 2026

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	29.5	-14.95%	🇺🇸 USA
Abbott Laboratories ABT	29.3	-15.67%	🇺🇸 USA
Medtronic MDT	22.8	-34.20%	🇮🇪 Ireland
Becton Dickinson BDX	50.1	44.39%	🇺🇸 USA
Edwards Lifesciences EW	45.7	31.56%	🇺🇸 USA
Tandem Diabetes Care TNDM	-13.9	-139.98%	🇺🇸 USA
QuidelOrtho QDEL	-0.9366	-102.70%	🇺🇸 USA
West Pharmaceutical Services WST	45.3	30.44%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.